Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial

scientific article

Description of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHOPHTHALMOL.2009.189
P698PubMed publication ID19752423
P5875ResearchGate publication ID26810418

P2093author name stringGui-shuang Ying
Maureen G Maguire
Judith Alexander
Andrew N Antoszyk
Complications of Age-related Macular Degeneration Prevention Trial Research Group
Revell W Martin
P433issue9
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
macular degenerationQ27429789
P1104number of pages5
P304page(s)1147-1151
P577publication date2009-09-01
P1433published inJAMA OphthalmologyQ4787301
P1476titleDescription of the Age-Related Eye Disease Study 9-step severity scale applied to participants in the Complications of Age-related Macular Degeneration Prevention Trial
P478volume127

Reverse relations

cites work (P2860)
Q38087692Aflibercept (VEGF Trap-Eye) for the treatment of exudative age-related macular degeneration
Q33676775Development of a risk score for geographic atrophy in complications of the age-related macular degeneration prevention trial
Q38218792Estrogen signalling in the pathogenesis of age-related macular degeneration.
Q36205759Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study
Q26774188Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects
Q38669197Geographic atrophy phenotype identification by cluster analysis.
Q91640890Use of Deep Learning for Detailed Severity Characterization and Estimation of 5-Year Risk Among Patients With Age-Related Macular Degeneration

Search more.